ESC COVID-19大流行期间心血管疾病诊疗指导:第二部分——照护路径、治疗与随访
该文件为ESC关于COVID-19大流行期间心血管疾病诊疗指导的第二部分,基于叙述性文献综述,聚焦照护路径与分诊系统、常见心血管疾病及COVID-19的管理治疗路径,以及帮助心血管病患者避免暴露的信息。它不是正式指南,推荐主要来自观察和医疗提供者个人经验,可能随知识更新而变化。
要点
- 提供COVID-19期间心血管病照护路径与分诊系统的实践指导。
- 涵盖常见心血管疾病及COVID-19的管理与治疗路径。
- 强调帮助心血管病患者避免COVID-19暴露的信息。
核心结论
- 该文件为叙述性综述而非正式指南,提供COVID-19大流行期间心血管疾病诊疗的当前知识与实践指导。
- 推荐主要基于医疗提供者的观察和个人经验,可能随新证据和疫情变化而更新。
- 文件内容不应干扰当地和国家卫生行政部门的建议。
研究设计与样本
- 采用叙述性文献综述方法,对现有证据进行总结并组织为两部分。
- 第二部分聚焦照护路径与分诊系统、常见心血管疾病及COVID-19的管理治疗路径、以及避免暴露的信息。
主要发现
- 第一部分已报告COVID-19患者可能表现的心血管状况的流行病学、病理生理学和诊断。
- 第二部分涉及照护路径与分诊系统、常见心血管疾病及COVID-19的管理与治疗路径。
- 第二部分还包含可帮助心血管病患者避免COVID-19暴露的信息。
临床怎么用
- 临床医生可参考该文件管理心血管疾病合并COVID-19的患者。
- 应结合当地和国家卫生行政部门的建议应用该指导。
- 需认识到推荐主要基于观察和个人经验,并随证据更新而调整。
局限性
- 该文件不是正式指南,推荐主要来自观察和医疗提供者个人经验。
- 信息可能随知识增加、前瞻性研究证据和疫情变化而改变。
- 文件不应干扰当地和国家卫生行政部门的建议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular (CV) disease in association with COVID-19. METHODS AND RESULTS: A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, which was reported previously, focused on the epidemiology, pathophysiology, and diagnosis of CV conditions that may be manifest in patients with COVID-19. This second part addresses the topics of: care pathways and triage systems and management and treatment pathways, both of the most commonly encountered CV conditions and of COVID-19; and information that may be considered useful to help patients with CV disease (CVD) to avoid exposure to COVID-19. CONCLUSION: This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.
引用
- ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J. 2022. PMID: 34791154. doi:10.1093/eurheartj/ehab697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。